Profiling Humoral Immunity After Mixing and Matching COVID-19 Vaccines Using SARS-CoV-2 Variant Protein Microarrays

In November 2022, 68% of the population received at least one dose of COVID-19 vaccines. Owing to the ongoing mutations, especially for the variants of concern (VOCs), it is important to monitor the humoral immune responses after different vaccination strategies. In this study, we developed a SARS-C...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Molecular & cellular proteomics Jg. 22; H. 4; S. 100507
Hauptverfasser:	Kuo, Ho-Chang, Kuo, Kuang-Che, Du, Pin-Xian, Keskin, Batuhan Birol, Su, Wen-Yu, Ho, Tzong-Shiann, Tsai, Pei-Shan, Pau, Chi Ho, Shih, Hsi-Chang, Huang, Ying-Hsien, Weng, Ken-Pen, Syu, Guan-Da
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States Elsevier Inc 01.04.2023 THE AUTHORS. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology
Schlagworte:	2019-nCoV Vaccine mRNA-1273 Antibodies, Neutralizing ChAdOx1 nCoV-19 COVID-19 COVID-19 - prevention & control COVID-19 Vaccines Humans Immunity, Humoral mix-and-match Protein Array Analysis protein microarray SARS-CoV-2 SARS-CoV-2 variants vaccine COVID-19 ACE2 VOCs vaccine RBD protein microarray mix-and-match ECD SARS-CoV-2 variants AZ M NTD
ISSN:	1535-9476, 1535-9484, 1535-9484
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!